Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-31
1997-06-03
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514321, 514326, 546 20, 546186, 546193, 546194, 546196, 546208, 546212, A61K 3144, A61K 31445, C07D47110, C07D40106
Patent
active
056355106
ABSTRACT:
The present invention relates to substituted pyrrolidinyl-3-yl-alkyl-piperidines, their stereoisomers, and pharmaceutically acceptable salts thereof and processes for preparation of the same. The compounds of the present invention are useful in their pharmacological activities such as tachykinin antagonism, especially substance P and neurokinin A antagonism, and the like. Compounds having the property of tachykinin antagonism are indicated for conditions associated with neurogenic inflammation and other diseases described herein.
REFERENCES:
patent: 4598079 (1986-07-01), Beyerle et al.
patent: 5166136 (1992-11-01), Ward
patent: 5340822 (1994-08-01), Emonds-Alt et al.
Melloni, et al., Eur. J. Med. Chem., 26, 207-213 (1991).
Emonds-Alt, et al., Life Sciences, 56(1):27-32, (1995).
Daijiro Hagiwara et. al., "Design of a Novel Dipeptide Substance P Antagoinst FK888 and Its Pharmacological Profile", Fujisawa Pharmacetucial Co., Ltd. (1985).
Yamashita, et al., Makromol Chem. 191, 1261-1268 (1990).
DiMaio, et al., J. Chem. Soc. Perkin Trans, 1989.
CA 107(23):217900f, Takase, et al., Tetrahedron, 42(21), 5887-5894, 1986.
CA 103(3): 22829z, Takase, et al, Tetrahedron Lett., 26(7), 847-850. (1985).
Schilling, et al., "Approaches towards the Design and Synthesis of Nonpeptidic Substance-P Antagonists", Ciba-Geigy Ltd., (15)207-220. (1993).
Logan, et al., "Recent Advances in Neurokinin Receptor Antagonists", Annual Reports in Medicinal Chemistry (26) 43-51. (1983).
Hagiwara, et al., J. Pharmacobio-Dyn., 14, s-104 (1991).
Roubini, et al., "1,4-Piperazine-derived, partially nonpeptidic analogs of Substance P", Hebrew University of Jerusalem, 161-162. (1985).
Chorev, et al., "Toward Nonpeptidal Substance P Mimetic Analogues: Design, Synthesis, and Biological Activity", Hebrew Uiv., 725-732. (1985).
Hagiwara, et al., J. Med. Chem, 36, 2266-2278, 1993.
Clark et al, "Principles of Psychopharmacology" Academic Press, pp. 166-167, (1970).
Burkholder Timothy P.
Kudlacz Elizabeth M.
Maynard George D.
Chang Ceila
Merrell Pharmaceuticals Inc.
Stemerick David M.
LandOfFree
Substituted pyrrolidin-3-yl-alkyl-piperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolidin-3-yl-alkyl-piperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolidin-3-yl-alkyl-piperidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391914